Article Information
History
- June 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sokratis A. Apostolidis1,2,3,#,
- Mihir Kakara4,5,#,
- Mark M. Painter1,3,6,#,
- Rishi R. Goel1,3,6,#,
- Divij Mathew1,3,6,
- Kerry Lenzi5,
- Ayman Rezk4,5,
- Kristina R. Patterson4,5,
- Diego A. Espinoza4,5,7,
- Jessy C. Kadri4,5,
- Daniel M. Markowitz4,5,
- Clyde Markowitz4,5,
- Ina Mexhitaj4,5,
- Dina Jacobs4,5,
- Allison Babb4,5,
- Michael R. Betts1,8,
- Eline T. Luning Prak1,9,
- Daniela Weiskopf10,
- Alba Grifoni10,
- Kendall A. Lundgreen8,11,
- Sigrid Gouma1,8,
- Alessandro Sette10,12,
- Paul Bates8,11,
- Scott E. Hensley1,8,
- Allison R. Greenplate1,3,
- E. John Wherry1,3,6,13,*,
- Rui Li4,5,* and
- Amit Bar-Or4,5,*
- 1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 2Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 3Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 4Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 5Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 6Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 7Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- 8Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 9Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 10Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
- 11Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 12Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
- 13Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- ↵*Corresponding authors: E. John Wherry. Email: wherry{at}pennmedicine.upenn.edu Rui Li. Email: lirui158{at}pennmedicine.upenn.edu Amit Bar-Or. Email: amitbar{at}pennmedicine.upenn.edu
↵# Contributed equally to this work.
Posted June 30, 2021.
Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
